ALGS vs ARE · rev $3.6M vs P/E 100, $13.19B cap
Aligos Therapeutics Inc (ALGS) versus Alexandria Real Estate Equities Inc (ARE) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
ARE does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Not investment advice. Open the ALGS and ARE stock pages for the full models.
Not investment advice.